Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Progesterone therapy in menopausal women:

Search results

Items: 1 to 20 of 3523

1.

HRT for women with premature ovarian insufficiency: a comprehensive review.

Webber L, Anderson RA, Davies M, Janse F, Vermeulen N.

Hum Reprod Open. 2017 Jul 12;2017(2):hox007. doi: 10.1093/hropen/hox007. eCollection 2017. Review.

2.

Experience of hormone replacement therapy in postmenopausal women living with HIV.

Howells P, Modarres M, Samuel M, Taylor C, Hamoda H.

Post Reprod Health. 2019 Mar 21:2053369119838737. doi: 10.1177/2053369119838737. [Epub ahead of print]

PMID:
30895862
3.

Veterans Health Administration Primary Care Provider Adherence to Prescribing Guidelines for Systemic Hormone Therapy in Menopausal Women.

Cordasco KM, Yuan AH, Danz MJ, Jackson L, Yee EF, Tcheung LS, Washington DL.

J Healthc Qual. 2019 Mar/Apr;41(2):99-109. doi: 10.1097/JHQ.0000000000000183.

PMID:
30839493
4.

Updating the role of obesity and cholesterol in breast cancer.

Garcia-Estevez L, Moreno-Bueno G.

Breast Cancer Res. 2019 Mar 1;21(1):35. doi: 10.1186/s13058-019-1124-1. Review.

5.

Ovarian insufficiency and CTNNB1 mutations drive malignant transformation of endometrial hyperplasia with altered PTEN/PI3K activities.

Terakawa J, Serna VA, Taketo MM, Daikoku T, Suarez AA, Kurita T.

Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 201814506. doi: 10.1073/pnas.1814506116. [Epub ahead of print]

6.

Menopausal Hormone Therapy and Risk of Diverticulitis.

Jovani M, Ma W, Joshi AD, Liu PH, Nguyen LH, Cao Y, Tam I, Wu K, Giovannucci EL, Chan AT, Strate LL.

Am J Gastroenterol. 2019 Feb;114(2):315-321. doi: 10.14309/ajg.0000000000000054.

PMID:
30730324
7.

Effect of Menopausal Hormone Therapy on Bone Mineral Density in Chinese Women: A 2-Year, Prospective, Open-Label, Randomized-Controlled Trial.

Zuo H, Sun A, Gao L, Xue W, Deng Y, Wang Y, Zhu S, Ma X, Xin H.

Med Sci Monit. 2019 Jan 28;25:819-826. doi: 10.12659/MSM.912166.

8.

HER2 overexpression and correlation with other significant clinicopathologic parameters in Ivorian breast cancer women.

Aman NA, Doukoure B, Koffi KD, Koui BS, Traore ZC, Kouyate M, Effi AB.

BMC Clin Pathol. 2019 Jan 17;19:1. doi: 10.1186/s12907-018-0081-4. eCollection 2019.

9.

Pregnancy, malignancy or mother nature? Persistence of high hCG levels in a perimenopausal woman.

Demir AY, Musson RE, Schöls WA, Duk JM.

BMJ Case Rep. 2019 Jan 3;12(1). pii: bcr-2018-227203. doi: 10.1136/bcr-2018-227203.

PMID:
30610037
10.

Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.

Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fiessler C, Hein A, Häberle L, Jud SM, Lux MP, Janni W, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kümmel S, Martin B, Thomssen C, Graf H, Wolf C, Bayer CM, Hack CC, Almstedt K, Gass P, Heindl F, Brodkorb TF, Nabieva N, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Wallwiener D, Rack B, Fehm T, Rody A, Maass N, Beckmann MW, Fasching PA, Rauh C.

Breast Cancer Res Treat. 2019 Apr;174(2):453-461. doi: 10.1007/s10549-018-05115-6. Epub 2019 Jan 2.

PMID:
30603996
11.

Associations of Dietary Patterns and Metabolic-Hormone Profiles with Breast Cancer Risk: A Case-Control Study.

Krusinska B, Wadolowska L, Slowinska MA, Biernacki M, Drozdowski M, Chadzynski T.

Nutrients. 2018 Dec 19;10(12). pii: E2013. doi: 10.3390/nu10122013.

12.

The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.

Temkin SM, Mallen A, Bellavance E, Rubinsak L, Wenham RM.

Cancer. 2019 Feb 15;125(4):499-514. doi: 10.1002/cncr.31911. Epub 2018 Dec 20. Review.

PMID:
30570740
13.

Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review.

Portman DJ, Goldstein SR, Kagan R.

Climacteric. 2019 Feb;22(1):65-72. doi: 10.1080/13697137.2018.1535583. Epub 2018 Dec 17.

PMID:
30554531
15.

The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.

Oliver-Williams C, Glisic M, Shahzad S, Brown E, Pellegrino Baena C, Chadni M, Chowdhury R, Franco OH, Muka T.

Hum Reprod Update. 2019 Mar 1;25(2):257-271. doi: 10.1093/humupd/dmy039.

PMID:
30508190
16.

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.

Simon JA, Kaunitz AM, Kroll R, Graham S, Bernick B, Mirkin S.

Menopause. 2018 Nov 26. doi: 10.1097/GME.0000000000001271. [Epub ahead of print]

PMID:
30489424
17.

Molecular Subtypes and Prognostic Factors among Premenopausal and Postmenopausal Thai Women with Invasive Breast Cancer: 15 Years Follow-up Data

Tubtimhin S, Promthet S, Suwanrungruang K, Supaattagorn P.

Asian Pac J Cancer Prev. 2018 Nov 29;19(11):3167-3174.

18.

Impact of micronized progesterone on body weight, body mass index, and glucose metabolism: a systematic review.

Coquoz A, Gruetter C, Stute P.

Climacteric. 2019 Apr;22(2):148-161. doi: 10.1080/13697137.2018.1514003. Epub 2018 Nov 27.

PMID:
30477366
19.

Pubertal Development and Pregnancy Outcomes in 46,XX Patients with Nonclassic Lipoid Congenital Adrenal Hyperplasia.

Hatabu N, Amano N, Mori J, Hasegawa Y, Matsuura H, Sumitomo N, Nishizawa K, Suzuki M, Katakura S, Kanamoto N, Kamimaki T, Ishii T, Hasegawa T.

J Clin Endocrinol Metab. 2018 Nov 23. doi: 10.1210/jc.2018-01752. [Epub ahead of print]

PMID:
30476142
20.

Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail.

Zhu SY, Deng Y, Wang YF, Xue W, Ma X, Sun A.

Gynecol Endocrinol. 2019 Feb;35(2):165-169. doi: 10.1080/09513590.2018.1505849. Epub 2018 Nov 19.

PMID:
30449208

Supplemental Content

Loading ...
Support Center